Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Virology|November 16, 2010
The N-terminal region of the human papillomavirus L2 protein contains overlapping binding sites for neutralizing, cross-neutralizing and non-neutralizing antibodiesIvonne Rubio, Hanna Seitz, Elena Canali, et al.
Bioorganic & Medicinal Chemistry|May 7, 2022
Short peptide pharmacophores developed from protein phosphatase-1 disrupting peptides (PDPs)Miriam Fontanillo, Malgorzata Trebacz, Christopher D Reinkemeier, et al.
Journal of Molecular Medicine (Berlin, Germany)|December 23, 2008
A novel peptide motif binding to and blocking the intracellular activity of the human papillomavirus E6 oncoproteinSusanne Dymalla, Martin Scheffner, Elvira Weber, et al.
Plos One|October 3, 2012
Automated high-throughput RNAi screening in human cells combined with reporter mRNA transfection to identify novel regulators of translationClaudia M Casanova, Peter Sehr, Kerstin Putzker, et al.
Journal of Cancer Research and Clinical Oncology|August 5, 2003
Dendritic cell-based tumor vaccine for cervical cancer II: results of a clinical pilot study in 15 individual patientsAlfonso Ferrara, Marion Nonn, Peter Sehr, et al.
The Journal of Infectious Diseases|November 26, 2013
Comparison of the immunogenicity and reactogenicity of Cervarix and Gardasil human papillomavirus vaccines in HIV-infected adults: a randomized, double-blind clinical trialLars Toft, Merete Storgaard, Martin Müller, et al.
The Journal of General Virology|December 20, 2007
Reactivity pattern of 92 monoclonal antibodies with 15 human papillomavirus typesRaeda Z Rizk, Neil D Christensen, Kristina M Michael, et al.
Human Vaccines & Immunotherapeutics|February 21, 2014
Comparison of the immunogenicity of Cervarix® and Gardasil® human papillomavirus vaccines for oncogenic non-vaccine serotypes HPV-31, HPV-33, and HPV-45 in HIV-infected adultsLars Toft, Martin Tolstrup, Martin Müller, et al.
Vaccine|February 21, 2016
Human Papillomavirus neutralizing and cross-reactive antibodies induced in HIV-positive subjects after vaccination with quadrivalent and bivalent HPV vaccinesHelena Faust, Lars Toft, Peter Sehr, et al.
Antiviral Therapy|February 22, 2007
A virosomal immunization strategy against cervical cancer and pre-malignant cervical diseaseLaura Bungener, Arjan de Mare, Jacqueline de Vries-Idema, et al.
Pageof 7